Start for free
Start for free
Pacira Pharmaceuticals logo

Pacira Pharmaceuticals

North America, California, United States, San Diego

Description

Pacira Pharmaceuticals is a specialty pharmaceutical company dedicated to postsurgical innovation.

Investor Profile

Pacira Pharmaceuticals has made 9 investments, with 0 in the past 12 months and 78% as lead.

Stage Focus

  • Convertible Note (44%)
  • Series Unknown (22%)
  • Series A (22%)
  • Series B (11%)

Country Focus

  • United States (78%)
  • Germany (22%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Medical
  • Health Care
  • Biopharma
  • Developer Tools
  • Life Science
  • Genetics
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pacira Pharmaceuticals frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 1
MPM Capital
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
DeepWork Capital
DeepWork Capital
North America, Florida, United States, Orlando
Co-Investments: 1
Versant Ventures
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Signet Healthcare Partners
Signet Healthcare Partners
North America, New York, United States, New York
Co-Investments: 1
Cercano Management
Cercano Management
North America, Washington, United States, Bellevue
Co-Investments: 2
UO
University of Florida Research Foundation
North America, Florida, United States, Gainesville
Co-Investments: 1
Quaker Partners
Quaker Partners
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 1
PC
Polymerase Capital
North America, Washington, United States, Seattle
Co-Investments: 1
Viscogliosi Brothers
Viscogliosi Brothers
North America, New York, United States, New York
Co-Investments: 2

What are some of recent deals done by Pacira Pharmaceuticals?

Spine BioPharma

New York, New York, United States

Spine BioPharma develops a non-surgical solution for back pain that eliminates pain and restores functionality.

BiotechnologyMedicalPharmaceutical
Convertible NoteFeb 8, 2023
Amount Raised: $13,000,000
CarthroniX

Lancaster, California, United States

CarthroniX is a pharmaceutical company that offers small molecule based therapy, wound healing, skin regeneration, and novel solutions.

BiotechnologyHealth CareMedicalPharmaceutical
Convertible NoteApr 11, 2022
Amount Raised: $2,250,000
Spine BioPharma

New York, New York, United States

Spine BioPharma develops a non-surgical solution for back pain that eliminates pain and restores functionality.

BiotechnologyMedicalPharmaceutical
Series BMar 28, 2022
Amount Raised: $13,000,000
Genascence

Palo Alto, California, United States

Clinical-stage biotechnology company developing life-changing gene therapy products for musculoskeletal diseases

Biotechnology
Series AJan 7, 2022
Amount Raised: $10,500,000
CODA Biotherapeutics

South San Francisco, California, United States

CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.

BiotechnologyGeneticsHealth CareMedicalTherapeutics
Series UnknownDec 2, 2021
Amount Raised: $28,000,000
Spine BioPharma

New York, New York, United States

Spine BioPharma develops a non-surgical solution for back pain that eliminates pain and restores functionality.

BiotechnologyMedicalPharmaceutical
Convertible NoteApr 20, 2021
Amount Raised: $3,000,000
GeneQuine Biotherapeutics

Hamburg, Hamburg, Germany

GeneQuine Biotherapeutics develops gene therapy for the treatment of osteoarthritis

BiopharmaBiotechnologyDeveloper ToolsHealth Care
Convertible NoteFeb 15, 2021
Amount Raised: $3,336,358
GeneQuine Biotherapeutics

Hamburg, Hamburg, Germany

GeneQuine Biotherapeutics develops gene therapy for the treatment of osteoarthritis

BiopharmaBiotechnologyDeveloper ToolsHealth Care
Series AFeb 15, 2021
Amount Raised: $6,551,394
TELA Bio

Malvern, Pennsylvania, United States

TELA Bio is a life science company that specializes in soft tissue reconstruction.

BiotechnologyLife SciencePharmaceutical
Series UnknownOct 30, 2017
Amount Raised: $25,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator